Building Automation Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Building Automation Systems Market
The building automation systems market size was valued at USD 73.80 billion in 2022, and the market is now projected to grow from USD 77.09 billion in 2023 to USD 130.13 billion by 2030, exhibiting a CAGR of 7.8% during the forecast period of 2023-2030.
The rising call for constructing automation systems is facing challenges because of the COVID-19 pandemic, resulting in deliver chain disruptions and semiconductor shortages. Strict change regulations and transient halts in creation activities have further slowed market boom, impacting economies and automation system demand.
The marketplace for building automation systems is set to flourish because of growing construction sports and the demand for technologically superior homes. Factors like urbanization, infrastructure improvement, and strength management structures are riding increase, permitting efficient power usage and improved protection. Government policies and electricity control standards similarly contribute to marketplace enlargement.
IoT-primarily based constructing automation structures offer profitable market growth possibilities by using enhancing electricity efficiency, real-time tracking, and safety. These structures permit far flung building operations, lessen working prices, and facilitate circumstance-based totally renovation for HVAC, lighting, and energy systems. Additionally, they offer controlled home equipment, progressed protection, and continuous tracking for easy protection and restore.
Comprehensive Analysis of Building Automation Systems Market
The building automation systems market growth is rising at an exponential rate due to its market segmentation. This marketplace enlargement successfully affords an in-depth local exam thinking about the dominant deliver and demand forces that effect the enterprise. These segmentations are methodically segregated by application analysis, by end user analysis, by end user vs. area size analysis. By application analysis include, HVAC systems, safety and security systems, energy systems, sanitization systems, and others. By end user analysis include, commercial, industrial, and residential. By end user vs. area size analysis include, residential, commercial, and industrial.
The North America region lead the building automation systems market share by benefitting a market size of USD 26.52 billion in 2022 due to rising awareness about energy-efficient buildings.
The pinnacle players inside the market play a critical function in the enterprise assuring market growth and placing marketplace requirements. These players include, Schneider Electric (France), Siemens AG (Germany), Cisco Systems (U.S.), Johnson Controls (U.S.), Robert Bosch (Germany), Hitachi (Japan), ABB (Switzerland), Carrier (U.S.), Legrand (France), Honeywell International (U.S.), and General Electric (U.S.) these market players provide a level-playing competitive landscape.
In March 2023, Siemens introduced Connect Box, an IoT solution tailored for smaller to medium-sized buildings, focusing on monitoring energy efficiency and enhancing indoor air quality.
Segmentation Table
Attribute Details
Study Period 2019 – 2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023 – 2030
Historical Period 2019 – 2021
Growth Rate CAGR of 7.8% from 2023 to 2030
Unit Value (USD billion)
Segmentation By Product Type, By Application, By End User, By End User vs. Area Size, and By Region
By Product Type Hardware
- Sensors
- Controllers
- Output Devices
- User Interface
Software
By Application HVAC Systems
Safety and Security Systems
Energy Systems
Sanitization Systems
Others (Vents, Pumping Systems)
By End User Residential
Commercial
- Offices Buildings
- Institutional Facilities
- Healthcare Facilities
- Hotels and Restaurants
- Retail Stores
- Others (Auditoriums, Museums, Galleries)
Industrial
By End User vs. Area Size Residential
- Up to 3,000 sq. ft.
- 3,000 to 10,000 sq. ft.
- Above 10,000 sq. ft.
Commercial
- Less than 25,000 sq. ft.
- 25,000 to 100,000 sq. ft.
- Above 100,000 sq. ft.
Industrial
- Below 50,000 sq. ft.
- 50,000 to 200,000 sq. ft.
- Above 200,000 sq. ft.
By Region North America (By Product Type, By Application, By End User, By End User vs. Area Size, and Country)
- U.S. (By Application)
- Canada (By Application)
- Mexico (By Application)
Europe (By Product Type, By Application, By End User, By End User vs. Area Size, and Country)
- U.K. (By Application)
- Germany (By Application)
- Italy (By Application
- France (By Application)
- Rest of Europe
Asia Pacific (By Product Type, By Application, By End User, By End User vs. Area Size, and Country)
- China (By Application)
- India (By Application)
- Japan (By Application)
- South Korea (By Application)
- Rest of Asia Pacific
Middle East and Africa (By Product Type, By Application, By End User, By End User vs. Area Size, and Country)
- South Africa (By Application)
- GCC (By Application)
- Rest of Middle East and Africa
South America (By Product Type, By Application, By End User, By End User vs. Area Size, and Country)
- Brazil (By Application)
- Argentina (By Application)
- Rest of South America
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Type 1 and Type 2 Diabetes Patients - For Key Countries, 2023
- 4.2. Penetration of Blood Glucose Monitoring Among Diabetes Patients, For Key Countries
- 4.3. Key Criteria for Selecting Blood Glucose Monitoring Systems
- 4.4. Regulatory/Reimbursement Overview, For Key Countries
- 4.5. Key Industry Developments – Mergers, Acquisitions & Partnerships
- 4.6. New Product Launches, By Key Players
- 4.7. Key Barriers to Market Entry
- 4.8. Pricing analysis – For Major Brands by Key Players
- 4.9. Impact of COVID-19 on the Market
- 5. Global Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Device Type
- 5.1.1. Continuous Glucose Monitoring (CGM) System
- 5.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 5.2. Market Analysis, Insights and Forecast – By Modality
- 5.2.1. Wearable
- 5.2.2. Non-wearable
- 5.3. Market Analysis, Insights and Forecast – By Type
- 5.3.1. Non-invasive
- 5.3.2. Invasive
- 5.4. Market Analysis, Insights and Forecast – By Patient Type
- 5.4.1. Type-1 Diabetes Patients
- 5.4.2. Type-2 Diabetes Patients
- 5.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.5.1. Retail Sales
- 5.5.2. Institutional Sales
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Rest of the World
- 6. North America Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Device Type
- 6.1.1. Continuous Glucose Monitoring (CGM) System
- 6.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 6.2. Market Analysis, Insights and Forecast – By Modality
- 6.2.1. Wearable
- 6.2.2. Non-wearable
- 6.3. Market Analysis, Insights and Forecast – By Type
- 6.3.1. Non-invasive
- 6.3.2. Invasive
- 6.4. Market Analysis, Insights and Forecast – By Patient Type
- 6.4.1. Type-1 Diabetes Patients
- 6.4.2. Type-2 Diabetes Patients
- 6.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.5.1. Retail Sales
- 6.5.2. Institutional Sales
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
- 6.7. U.S. Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 6.7.1. Market Analysis, Insights and Forecast – By Device Type
- 6.7.1.1. Continuous Glucose Monitoring (CGM) System
- 6.7.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 6.7.2. Market Analysis, Insights and Forecast – By Modality
- 6.7.2.1. Wearable
- 6.7.2.2. Non-wearable
- 6.7.3. Market Analysis, Insights and Forecast – By Type
- 6.7.3.1. Non-invasive
- 6.7.3.2. Invasive
- 6.7.4. Market Analysis, Insights and Forecast – By Patient Type
- 6.7.4.1. Type-1 Diabetes Patients
- 6.7.4.2. Type-2 Diabetes Patients
- 6.7.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.7.5.1. Retail Sales
- 6.7.5.2. Institutional Sales
- 6.8. Canada Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 6.8.1. Market Analysis, Insights and Forecast – By Device Type
- 6.8.1.1. Continuous Glucose Monitoring (CGM) System
- 6.8.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 6.8.2. Market Analysis, Insights and Forecast – By Modality
- 6.8.2.1. Wearable
- 6.8.2.2. Non-wearable
- 6.8.3. Market Analysis, Insights and Forecast – By Type
- 6.8.3.1. Non-invasive
- 6.8.3.2. Invasive
- 6.8.4. Market Analysis, Insights and Forecast – By Patient Type
- 6.8.4.1. Type-1 Diabetes Patients
- 6.8.4.2. Type-2 Diabetes Patients
- 6.8.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.8.5.1. Retail Sales
- 6.8.5.2. Institutional Sales
- 7. Europe Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Device Type
- 7.1.1. Continuous Glucose Monitoring (CGM) System
- 7.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.2. Market Analysis, Insights and Forecast – By Modality
- 7.2.1. Wearable
- 7.2.2. Non-wearable
- 7.3. Market Analysis, Insights and Forecast – By Type
- 7.3.1. Non-invasive
- 7.3.2. Invasive
- 7.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.4.1. Type-1 Diabetes Patients
- 7.4.2. Type-2 Diabetes Patients
- 7.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.5.1. Retail Sales
- 7.5.2. Institutional Sales
- 7.6. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Spain
- 7.6.5. Italy
- 7.6.6. Rest of Europe
- 7.7. U.K. Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.7.1. Market Analysis, Insights and Forecast – By Device Type
- 7.7.1.1. Continuous Glucose Monitoring (CGM) System
- 7.7.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.7.2. Market Analysis, Insights and Forecast – By Modality
- 7.7.2.1. Wearable
- 7.7.2.2. Non-wearable
- 7.7.3. Market Analysis, Insights and Forecast – By Type
- 7.7.3.1. Non-invasive
- 7.7.3.2. Invasive
- 7.7.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.7.4.1. Type-1 Diabetes Patients
- 7.7.4.2. Type-2 Diabetes Patients
- 7.7.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.7.5.1. Retail Sales
- 7.7.5.2. Institutional Sales
- 7.8. Germany Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.8.1. Market Analysis, Insights and Forecast – By Device Type
- 7.8.1.1. Continuous Glucose Monitoring (CGM) System
- 7.8.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.8.2. Market Analysis, Insights and Forecast – By Modality
- 7.8.2.1. Wearable
- 7.8.2.2. Non-wearable
- 7.8.3. Market Analysis, Insights and Forecast – By Type
- 7.8.3.1. Non-invasive
- 7.8.3.2. Invasive
- 7.8.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.8.4.1. Type-1 Diabetes Patients
- 7.8.4.2. Type-2 Diabetes Patients
- 7.8.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.8.5.1. Retail Sales
- 7.8.5.2. Institutional Sales
- 7.9. France Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.9.1. Market Analysis, Insights and Forecast – By Device Type
- 7.9.1.1. Continuous Glucose Monitoring (CGM) System
- 7.9.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.9.2. Market Analysis, Insights and Forecast – By Modality
- 7.9.2.1. Wearable
- 7.9.2.2. Non-wearable
- 7.9.3. Market Analysis, Insights and Forecast – By Type
- 7.9.3.1. Non-invasive
- 7.9.3.2. Invasive
- 7.9.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.9.4.1. Type-1 Diabetes Patients
- 7.9.4.2. Type-2 Diabetes Patients
- 7.9.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.9.5.1. Retail Sales
- 7.9.5.2. Institutional Sales
- 7.10. Spain Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.10.1. Market Analysis, Insights and Forecast – By Device Type
- 7.10.1.1. Continuous Glucose Monitoring (CGM) System
- 7.10.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.10.2. Market Analysis, Insights and Forecast – By Modality
- 7.10.2.1. Wearable
- 7.10.2.2. Non-wearable
- 7.10.3. Market Analysis, Insights and Forecast – By Type
- 7.10.3.1. Non-invasive
- 7.10.3.2. Invasive
- 7.10.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.10.4.1. Type-1 Diabetes Patients
- 7.10.4.2. Type-2 Diabetes Patients
- 7.10.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.10.5.1. Retail Sales
- 7.10.5.2. Institutional Sales
- 7.11. Italy Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.11.1. Market Analysis, Insights and Forecast – By Device Type
- 7.11.1.1. Continuous Glucose Monitoring (CGM) System
- 7.11.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.11.2. Market Analysis, Insights and Forecast – By Modality
- 7.11.2.1. Wearable
- 7.11.2.2. Non-wearable
- 7.11.3. Market Analysis, Insights and Forecast – By Type
- 7.11.3.1. Non-invasive
- 7.11.3.2. Invasive
- 7.11.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.11.4.1. Type-1 Diabetes Patients
- 7.11.4.2. Type-2 Diabetes Patients
- 7.11.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.11.5.1. Retail Sales
- 7.11.5.2. Institutional Sales
- 7.12. Rest of Europe Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.12.1. Market Analysis, Insights and Forecast – By Device Type
- 7.12.1.1. Continuous Glucose Monitoring (CGM) System
- 7.12.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 7.12.2. Market Analysis, Insights and Forecast – By Modality
- 7.12.2.1. Wearable
- 7.12.2.2. Non-wearable
- 7.12.3. Market Analysis, Insights and Forecast – By Type
- 7.12.3.1. Non-invasive
- 7.12.3.2. Invasive
- 7.12.4. Market Analysis, Insights and Forecast – By Patient Type
- 7.12.4.1. Type-1 Diabetes Patients
- 7.12.4.2. Type-2 Diabetes Patients
- 7.12.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.12.5.1. Retail Sales
- 7.12.5.2. Institutional Sales
- 8. Asia Pacific Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Device Type
- 8.1.1. Continuous Glucose Monitoring (CGM) System
- 8.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.2. Market Analysis, Insights and Forecast – By Modality
- 8.2.1. Wearable
- 8.2.2. Non-wearable
- 8.3. Market Analysis, Insights and Forecast – By Type
- 8.3.1. Non-invasive
- 8.3.2. Invasive
- 8.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.4.1. Type-1 Diabetes Patients
- 8.4.2. Type-2 Diabetes Patients
- 8.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.5.1. Retail Sales
- 8.5.2. Institutional Sales
- 8.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. South Korea
- 8.6.6. Rest of Asia Pacific
- 8.7. Japan Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.7.1. Market Analysis, Insights and Forecast – By Device Type
- 8.7.1.1. Continuous Glucose Monitoring (CGM) System
- 8.7.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.7.2. Market Analysis, Insights and Forecast – By Modality
- 8.7.2.1. Wearable
- 8.7.2.2. Non-wearable
- 8.7.3. Market Analysis, Insights and Forecast – By Type
- 8.7.3.1. Non-invasive
- 8.7.3.2. Invasive
- 8.7.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.7.4.1. Type-1 Diabetes Patients
- 8.7.4.2. Type-2 Diabetes Patients
- 8.7.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.7.5.1. Retail Sales
- 8.7.5.2. Institutional Sales
- 8.8. China Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.8.1. Market Analysis, Insights and Forecast – By Device Type
- 8.8.1.1. Continuous Glucose Monitoring (CGM) System
- 8.8.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.8.2. Market Analysis, Insights and Forecast – By Modality
- 8.8.2.1. Wearable
- 8.8.2.2. Non-wearable
- 8.8.3. Market Analysis, Insights and Forecast – By Type
- 8.8.3.1. Non-invasive
- 8.8.3.2. Invasive
- 8.8.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.8.4.1. Type-1 Diabetes Patients
- 8.8.4.2. Type-2 Diabetes Patients
- 8.8.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.8.5.1. Retail Sales
- 8.8.5.2. Institutional Sales
- 8.9. India Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.9.1. Market Analysis, Insights and Forecast – By Device Type
- 8.9.1.1. Continuous Glucose Monitoring (CGM) System
- 8.9.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.9.2. Market Analysis, Insights and Forecast – By Modality
- 8.9.2.1. Wearable
- 8.9.2.2. Non-wearable
- 8.9.3. Market Analysis, Insights and Forecast – By Type
- 8.9.3.1. Non-invasive
- 8.9.3.2. Invasive
- 8.9.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.9.4.1. Type-1 Diabetes Patients
- 8.9.4.2. Type-2 Diabetes Patients
- 8.9.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.9.5.1. Retail Sales
- 8.9.5.2. Institutional Sales
- 8.10. Australia Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.10.1. Market Analysis, Insights and Forecast – By Device Type
- 8.10.1.1. Continuous Glucose Monitoring (CGM) System
- 8.10.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.10.2. Market Analysis, Insights and Forecast – By Modality
- 8.10.2.1. Wearable
- 8.10.2.2. Non-wearable
- 8.10.3. Market Analysis, Insights and Forecast – By Type
- 8.10.3.1. Non-invasive
- 8.10.3.2. Invasive
- 8.10.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.10.4.1. Type-1 Diabetes Patients
- 8.10.4.2. Type-2 Diabetes Patients
- 8.10.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.10.5.1. Retail Sales
- 8.10.5.2. Institutional Sales
- 8.11. South Korea Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.11.1. Market Analysis, Insights and Forecast – By Device Type
- 8.11.1.1. Continuous Glucose Monitoring (CGM) System
- 8.11.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.11.2. Market Analysis, Insights and Forecast – By Modality
- 8.11.2.1. Wearable
- 8.11.2.2. Non-wearable
- 8.11.3. Market Analysis, Insights and Forecast – By Type
- 8.11.3.1. Non-invasive
- 8.11.3.2. Invasive
- 8.11.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.11.4.1. Type-1 Diabetes Patients
- 8.11.4.2. Type-2 Diabetes Patients
- 8.11.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.11.5.1. Retail Sales
- 8.11.5.2. Institutional Sales
- 8.12. Rest of Asia Pacific Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.12.1. Market Analysis, Insights and Forecast – By Device Type
- 8.12.1.1. Continuous Glucose Monitoring (CGM) System
- 8.12.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 8.12.2. Market Analysis, Insights and Forecast – By Modality
- 8.12.2.1. Wearable
- 8.12.2.2. Non-wearable
- 8.12.3. Market Analysis, Insights and Forecast – By Type
- 8.12.3.1. Non-invasive
- 8.12.3.2. Invasive
- 8.12.4. Market Analysis, Insights and Forecast – By Patient Type
- 8.12.4.1. Type-1 Diabetes Patients
- 8.12.4.2. Type-2 Diabetes Patients
- 8.12.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.12.5.1. Retail Sales
- 8.12.5.2. Institutional Sales
- 9. Rest of the World Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Device Type
- 9.1.1. Continuous Glucose Monitoring (CGM) System
- 9.1.2. Self-Monitoring Blood Glucose (SMBG) System
- 9.2. Market Analysis, Insights and Forecast – By Modality
- 9.2.1. Wearable
- 9.2.2. Non-wearable
- 9.3. Market Analysis, Insights and Forecast – By Type
- 9.3.1. Non-invasive
- 9.3.2. Invasive
- 9.4. Market Analysis, Insights and Forecast – By Patient Type
- 9.4.1. Type-1 Diabetes Patients
- 9.4.2. Type-2 Diabetes Patients
- 9.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.5.1. Retail Sales
- 9.5.2. Institutional Sales
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2023)
- 10.2. Company Profiles
- 10.2.1. Abbott
- 10.2.1.1. Overview
- 10.2.1.2. Products & Services
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. Financials (Based on Availability)
- 10.2.2. Dexcom, Inc.
- 10.2.2.1. Overview
- 10.2.2.2. Products & Services
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. Financials (Based on Availability)
- 10.2.3. Ascensia Diabetes Care Holdings AG
- 10.2.3.1. Overview
- 10.2.3.2. Products & Services
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. Financials (Based on Availability)
- 10.2.4. B. Braun SE
- 10.2.4.1. Overview
- 10.2.4.2. Products & Services
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. Financials (Based on Availability)
- 10.2.5. Medtronic
- 10.2.5.1. Overview
- 10.2.5.2. Products & Services
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. Financials (Based on Availability)
- 10.2.6. LifeScan IP Holdings, LLC
- 10.2.6.1. Overview
- 10.2.6.2. Products & Services
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. Financials (Based on Availability)
- 10.2.7. F. Hoffmann-La Roche Ltd.
- 10.2.7.1. Overview
- 10.2.7.2. Products & Services
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. Financials (Based on Availability)
- 10.2.8. Terumo Corporation
- 10.2.8.1. Overview
- 10.2.8.2. Products & Services
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. Financials (Based on Availability)
- 10.2.9. Senseonics
- 10.2.9.1. Overview
- 10.2.9.2. Products & Services
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Strategies
- 10.2.9.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook